home / stock / epgny / epgny quote
Last: | $2.39 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $2.39 |
High: | $0 |
Low: | $0 |
Volume: | 112 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.39 | $0 | $2.39 | $0 | $0 | 112 | 12-28-2022 |
$2.39 | $2.38 | $2.39 | $2.39 | $2.38 | 212 | 09-21-2022 |
$2.29 | $2.005 | $2.29 | $2.29 | $2.005 | 407 | 09-15-2022 |
$2.8 | $0 | $2.8 | $0 | $0 | 10 | 08-24-2022 |
$2.8 | $0 | $2.8 | $0 | $0 | 82 | 08-18-2022 |
$2.8 | $0 | $2.8 | $0 | $0 | 12 | 08-15-2022 |
$2.8 | $0 | $2.8 | $0 | $0 | 1 | 08-11-2022 |
$2.8 | $2.8 | $2.8 | $2.8 | $2.8 | 100 | 03-07-2022 |
$2.93 | $2.93 | $2.93 | $2.93 | $2.93 | 161 | 02-14-2022 |
$3.5699 | $3.5699 | $3.5699 | $3.5699 | $3.5699 | 175 | 01-04-2022 |
$3.54 | $3.54 | $3.54 | $3.54 | $3.54 | 1,100 | 12-28-2021 |
$3.065 | $3.065 | $3.065 | $3.065 | $3.065 | 312 | 12-27-2021 |
$7 | $7 | $7 | $7 | $7 | 700 | 09-08-2021 |
$8 | $8 | $8 | $8 | $8 | 700 | 09-06-2021 |
$8 | $8 | $8 | $8 | $8 | 700 | 09-03-2021 |
$7.55 | $7.55 | $7.55 | $7.55 | $7.55 | 100 | 09-01-2021 |
$7.8 | $7.8 | $7.8 | $7.8 | $7.8 | 100 | 06-15-2021 |
$7.8 | $7.8 | $7.8 | $7.8 | $7.8 | 179 | 05-06-2021 |
$12.39 | $12.39 | $12.39 | $12.39 | $12.39 | 250 | 04-16-2021 |
$13.77 | $13.77 | $13.77 | $13.77 | $13.77 | 252 | 03-15-2021 |
News, Short Squeeze, Breakout and More Instantly...
Epigenomics Ag S/Adr Company Name:
EPGNY Stock Symbol:
OTCMKTS Market:
Under the primary base case analysis, annual m SEPT9 screening resulted in more Quality-adjusted-life-years gained (QALYG), CRC cases averted and CRC deaths averted than both annual FIT screening and Cologuard ® every three years, albeit at a higher colonoscopy referral rate ...
Dover, Delaware--(Newsfile Corp. - June 17, 2020) - Encode Ideas, L.P. Initiates Research on Epigenomics AG (Xetra: ECX.DE) (FSE: ECX) (OTC: EPGNF). The full research publication is available here and available on our website at www.encodelp.com . A summary follows: Encode Ideas, L.P., a h...
- Adherence rates and screening intervals recognized as decisive elements of successful screening strategies - BERLIN, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”), today reported on micro-simulation model results indicating th...